基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件_第1頁(yè)
基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件_第2頁(yè)
基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件_第3頁(yè)
基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件_第4頁(yè)
基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件_第5頁(yè)
已閱讀5頁(yè),還剩155頁(yè)未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

基底神經(jīng)節(jié)疾病基底神經(jīng)節(jié)疾病Outline1.IntroductionofbasalgangliaOverviewandfunction,structure,andconnections2.DisordersofbasalgangliaParkinson’sdiseaseHuntington’sdisease(symptomatology,pathology,pothogenesis,treatment…)Outline1.Introductionofbasal1.IntroductionofbasalgangliaOverviewandfunctionStructureConnections

1.IntroductionofbasalgangliThe

basalganglia

areagroupofnucleiinthebraininterconnectedwiththecerebralcortex,thalamusandbrainstem.

Functions:

motorcontrol,cognition,emotions,andlearning.Thebasalgangliaareagroup錐體系統(tǒng)錐體系統(tǒng)internalglobuspallidus(GPi)externalglobuspallidus(GPe)

internalglobuspallidus基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件ConnectionsConnectionsCircuitofBasalGangliaDirectpathwayIndirectpathwayNigrostriatalpathwayCircuitofBasalGangliaDirectGlutamateGABA

Dopamine

GlutamateDirect:

Motorcortex→Putamen→GPi→Thalamus→Motorcortex

Indirect:

Motorcortex→Putamen→GPe→Subthalamicnucleus→GPi→Thalamus→MotorcortexNigrostriatalpathway:

Parscompacta→StriatumGluGABAGABAGluGluGABAGABAGluGABAGluDirect:Motorcortex→Putam2.DisordersofBasalGangliaDiminishedmovement:Parkinson’sdiseaseExcessivemovement:HuntingtondiseaseNeuropsychiatriccognitiveandbehavioraldisturbances2.DisordersofBasalGangliaParkinson’sdisease,PD"AnEssayontheShakingPalsy"EnglishphysicianJamesParkinson(1817)IntroductionPDisthemostcommonneurodegenerativedisorderafterAlzheimer'sdisease.Parkinson’sdisease,PD"AnEssaTheprevalenceis0.3inthewholepopulationinindustrializedcountries,risingto1%inthoseover60yearsofageandto4%ofthepopulationover80.Meanageofonsetisaround60years,although5-10%ofcasesareconsideredofyoungonset(theageof20and50).Theincidenceisbetween8and18per100.000person-years.EpidemiologyTheprevalenceis0.3inthewMonographbyJamesParkinson1817SymptomatologyMovementdisorders:restingtremormusclerigiditybradykinesiaandposturalinstability

ParkinsonismCognitiveandneurobehavioralproblems(dementia)Sensoryandsleepdifficulties

chronicandprogressiveMonographbyJamesParkinsonSyTherelationshipofthebasalgangliatothemajorcomponentsofthemotorsystem.

TherelationshipofthebasalOriginsandterminationsof(a)thecorticospinaltractand(b)therubrospinaltract.Originsandterminationsof(a正常年青人,黑質(zhì)細(xì)胞數(shù)為42.5萬(wàn)

正常80歲老人,黑質(zhì)細(xì)胞數(shù)減少到20.0萬(wàn)

PD病人黑質(zhì)細(xì)胞數(shù)減少到少于10.0萬(wàn)

LewybodyPathology正常年青人,黑質(zhì)細(xì)胞數(shù)為42.5萬(wàn)

正常80歲老人,黑質(zhì)細(xì)胞Etiology

Etiology

PathogenesisCircuitdisorderofBasalGangliaGeneticDopamineoxidativestressToxinsOthersPathogenesisCircuitdisorderoCircuitdisorderofBasalGangliainhibitionofthedirectpathwayexcitationoftheindirectpathwayCircuitdisorderofBasalGang基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件多巴胺神經(jīng)元為何會(huì)發(fā)生黑質(zhì)部選擇性的退行性變呢?氧化應(yīng)激損傷1、外源性毒物的侵入2、神經(jīng)黑色素的存在3、DA的氧化應(yīng)激代謝4、清除自由基的能力不全多巴胺神經(jīng)元為何會(huì)發(fā)生黑質(zhì)部選擇性的退行性變呢?氧化應(yīng)激損傷圖31-5多巴胺在神經(jīng)元中的酶代謝及其代謝產(chǎn)物引自金國(guó)章,腦內(nèi)多巴胺的生物醫(yī)學(xué)1998年Fe2+Fe3+O2O2·ˉFe2+Fe3+O2O2·ˉH2O2多巴胺半醌多巴胺醌DAO2MAODOPACH2O2HVACOMTDopamineoxidativestress圖31-5多巴胺在神經(jīng)元中的酶代謝及其代謝產(chǎn)物Fe2+FeDopamineoxidativestressDopamineoxidativestressToxinsRotenone(aninsecticide)MPTP1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(1-甲基-4-苯基-1,2,3,6-四氫吡啶)Paraquat(aherbicide)6-Hydroxydopamine(6-OHDA)

HeavymetalsToxinsRotenone(aninsecticideRotenoneRotenoneMPTPMPTPParaquatParaquat6-Hydroxydopamine,or6-OHDA

6-Hydroxydopamine,or6-OHDATheneurotoxinsusedinanimalmodelsofPDinducemitochondrialdysfunction.Theneurotoxinsusedinanimal一種理想的動(dòng)物模型應(yīng)該符合下列5種標(biāo)準(zhǔn):

1.出生時(shí),應(yīng)有正常而完整的DAneurons,并在成年期開(kāi)始逐漸退化喪失且超過(guò)50%。

2.具有容易檢測(cè)的運(yùn)動(dòng)功能障礙。

3.Lewybodies的形成。

4.如模式是genetic,應(yīng)以單一點(diǎn)突變?yōu)榛A(chǔ)。

5.較短的時(shí)程,約數(shù)月。一種理想的動(dòng)物模型應(yīng)該符合下列5種標(biāo)準(zhǔn):

1.出生時(shí),應(yīng)有基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件Geneticmitochondrialdysfunction,oxidativedamage,abnormalproteinaccumulationandproteinphosphorylation

Geneticmitochondrialdysfuncti1.Synuclein(SNCA)/PARK1seenmainlyinpresynapticterminalsincludeα,βandγ-synucleinplayaroleinsynapticvesiclerecycling,storageandcompartmentalizationofneurotransmittersandassociateswithvesicularandmembranousstructures1.Synuclein(SNCA)/PARK1seenmSer129的磷酸化

-synuclein基因的倍增

Ser129的磷酸化

-synuclein基因的倍增Overviewofthea-synaggregationprocessintegratedwiththeoxidativestresspathwayandtheUPP.Overviewofthea-synaggregatParkinfunctionsasanE3ubiquitinproteinligasebytargetingmisfoldedproteinstotheubiquitnproteasomepathwayfordegradation,andthelossofitsE3ligaseactivityduetomutationsleadtoautosomalrecessiveearly-onsetPD.2.Parkin/PARK2ParkinfunctionsasanE3ubiqubiquitinproteasomesystem,UPS

ubiquitinproteasomesystem,UP3.PINK1(PTEN-inducedputativekinase1)/PARK6serine–threoninekinase(mitochondria)apivotalregulatorofmitochondrialquality3.PINK1(PTEN-inducedputative4.UCH-L1/PARK5utativekinase1(PINK1)Ubiquitincarboxyl-terminalhydrolaseL1neuron-specificproteinPGP9.5oneofthemostabundantproteinsinthebrain(2%)hydrolyticactivity,ligaseactivityandbindingmono-ub4.UCH-L1/PARK5utativekinase1PossibleroleofUCH-L1inPD.PossibleroleofUCH-L1inPD.基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件Mechanismsofneurotoxicant-inducedproteasomedysfunctionanddopaminergicdegeneration.Mechanismsofneurotoxicant-inTransgenicanimalmodelalpha-synucleinA30P+A53T,LRRK2(R1441G),parkin,R621Csynphilin-1…mouse,C.elegans,Drosophila,zebrafish

Transgenicanimalmodelalpha-Inflammation

Neuroinflammationismediatedpredominatelybymicroglia,theresidentimmuno-competentandphagocyticcellswithintheCNS.Microglia,representing5?20%ofbraincellsMicroglialcelldensityintheSNis4?5timeshigherthaninotherregionsActivatedcellsalsoproducepro-inflammatorymoleculesInflammation

Neuroinflammation基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件Schematicrepresentationoflipopolysaccharide(LPS)-inducedandglialactivation-mediateddopamine(DA)neurodegeneration.SchematicrepresentationoflKeymolecularmechanismsthatarewidelyacceptedtocontributetotheneurodegenerativeprocessindopaminergicneuronsinthesubstantianigrainParkinsondisease.KeymolecularmechanismsthatAtleasttwoofthethreemajorsymptomsarepresent.PossiblecausesforsymptomsResponsetolevodopaThemaintoolsusedtomakeadiagnosis:NeurologicalexaminationMotorphysiologytestsNeuro-imaging:PET(18-flurodopa),CT,MRI

Lewybodiesduringautopsy(goldstandard)

DiagnosisAtleasttwoofthethreemajo基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件Treatment

ThereisnoknowncureforParkinson'sdisease.Treatmentisaimedatcontrollingthesymptoms.Medicationscontrolsymptomsprimarilybycontrollingtheimbalancebetweenthetransmitters.TreatmentThereisnoknownTherapeuticstrategyDirectlyimprovethefunctionofdopamineneurotransmissionIndirectlyimprovethefunctionofdopamineSurgeryanddeepbrainstimulationTherapeuticstrategyDirectlyidopamine↑inthebrain

PrecursorRate-limitingstep,decreaseinPDL-dopadopamine↑inthebrainPrecursPeripheralinhibitorsThecentralandperipheralmetabolismoflevodopaanditsmodificationbydrugs.PeripheralinhibitorsThecentreasilypassthroughtheblood-brainbarrieristransformedintodopamineinthedopaminergicneuronsbyDDCisoftenmetabolisedtoDAelsewhere,causingawidevarietyofsideeffectsCOMTinhibitors,MAO-BinhibitorsL-dopaeasilypassthroughtheblood-Long-termeffectsofL-DOPA:

On/offoscillationsDosefailure(drugresistance)DopaminedysregulationsyndromeLong-termeffectsofL-DOPA:Ach:

movementAchincreasesinhibitionof

GABA.Adenosine:movementAdenosineincreasetheeffectsofAchontheGABAergicneurons;AdenosinecounterD2receptoractivity;AdenosinereducesGABArelease.Ach:movementEnkephalinDynorphinPeptidemodulationofstriatalinputtotheglobuspollidus.EnkephalinPeptidemodulationPallidotomyandSubthalamotomy

PallidotomyandSubthalamotomySurgeryisusedinpeoplewithadvancedPDforwhomdrugtherapyisnolongersufficient.Becausetheseprocedurescausepermanentdestructionofbraintissue,theyhavelargelybeenreplacedbydeepbrainstimulation(DBS)fortreatmentofParkinson'sdisease.SurgeryisusedinpeoplewithDBSisprimarilyusedtostimulateoneofthreebrainregions:thesubthalamicnucleus,theglobuspallidus,orthethalamus.DBSisprimarilyusedtostimuResearchdirections

Animalmodels

Genetherapy(virus)Neuroprotectivetreatments

(GDNF)Neuraltransplantation

Stemcellstransplantshaveraisedgreatrecentinterest.Whentransplantedintothebrainsofrodentsandmonkeystheysurviveandimprovebehavioralabnormalities.Neverthelesswhilefetalstemcellsaretheeasiesttomanipulatetheiruseiscontroversial.Suchcontroversymaybeovercomewiththeuseofinducedpluripotentstemcellsfromadults.

ResearchdirectionsAnimalmodAschemeofthegenerationofinducedpluripotentstem(iPS)cells.

(1)Isolateandculturedonorcells.(2)Transfectstemcell-associatedgenesintothecellsbyviralvectors.Redcellsindicatethecellsexpressingtheexogenousgenes.(3)HarvestandculturethecellsaccordingtoEScellculture,usingmitoticallyinactivatedfeedercells(lightgray).(4)AsmallsubsetofthetransfectedcellsbecomeiPScellsandgenerateES-likecolonies.

Aschemeofthegenerationof主要講解的內(nèi)容:1.

基底神經(jīng)節(jié)的腦內(nèi)組成的核團(tuán)、它們的分布、主要通路的組成及其參與調(diào)節(jié)每條通路中的神經(jīng)遞質(zhì)及其功能。2.

基底神經(jīng)節(jié)(黑質(zhì))損傷后的主要臨床表現(xiàn)及其病理表現(xiàn)的關(guān)系。3.PD腦內(nèi)黑質(zhì)多巴胺神經(jīng)元退化的機(jī)制研究。4.Parkinson’sDisease(PD)的治療方案及治療基礎(chǔ)。主要講解的內(nèi)容:思考題:1.Whatarethecomponentsofthebasalganglia?2.Howarethestructuresofthebasalgangliaconnected?3.Describethecorticostriatalprojections.4.Describetheconnectionsbetweensubthalamusandglobuspallidus.5.Describetheimportanceofthenigrastritalpathways.6.Whatistheroleofthebasalgangliainrelationtothemotorthalamus?7.Whataretheprincipalneurotransmittersandreceptorsassociatedwiththebasalganglia?8.Adisorderofthebasalgangliaisindicatedwhatsigns?9.CanadministrationofdopaminecureParkinson’sdisease?Why?10.DescribetheetiologyofneurodegenerationinthesubstantianigrainPD.11.WhydoselesioningtheSThnorGPreducethesymptomsofPD?

思考題:Huntington'sdisease(HD)In1872GeorgeHuntingtonthoroughlydescribedthedisorderinhisfirstpaper"OnChorea".IntroductionTheworldwideprevalenceofHDis5-10casesper100,000persons.

Itusuallyappearsinmiddleage(30-50years)EpidemiologyHuntington'sdisease(HD)IntroHD/chorea

isaninherited(autosomaldominantinheritance)progressiveneurodegenerativedisorder,whichaffectsmusclecoordinationandleadstocognitivedeclineanddementia.Ittypicallybecomesnoticeableinmiddleage.abnormalitiesinperipheraltissues(muscleatrophy,cardiacfailure,impairedglucosetolerance…)SymptomatologyHD/choreaisaninherited(aProminentcelllossandatrophyinstriatum.astrocytes↑PathologynuclearandcytoplasmicinclusionsProminentcelllossandatrophPathogenesisPathogenesisPathogenesisPathogenesisHttisexpressedinallmammaliancells.(brain)interactswithover100otherproteins,andappearstohavemultiplebiologicalfunctions.embryonicdevelopment,anti-apoptosis,controlingtheproductionofBDNF,facilitatingvesiculartransportandsynaptictransmission,andcontrolingneuronalgenetranscription.Pathogenesis1.LossofHttfunction

2.ToxicfunctionofmHttHttisexpressedinallmammal基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件GlutamateGABA

Dopamine

GlutamateDiagnosis

typicalsymptomsafamilyhistoryofthediseasegenetictestingtohavetheexpandedtrinucleotiderepeatphysicalexamination,psychologicalexamination,Medicalimaging

DiagnosistypicalsymptomsThereisnoknowncureforHD.Treatmentisaimedatcontrollingthesymptoms.tetrabenazine(chorea)antipsychoticdrugs

TreatmentThereisnoknowncureforHD.Prognosis

Thelengthofthetrinucleotiderepeataccountsfor60%ofthevariationintheageofonsetandtherateofprogressionofsymptoms.Alongerrepeatresultsinanearlierageofonsetandafasterprogressionofsymptoms.

LifeexpectancyinHDisgenerallyaround20

yearsfollowingtheonsetofvisiblesymptoms.PrognosisThelengthofthetrResearchdirections

Appropriateanimalmodels(transgenicanimals)Geneticallyengineeredintrabodies(aninhibitionofmHttaggregation)havebeenshowntopreventmortalityduringthedevelopment

stagesofDrosophilamodels.Genesilencing(mHttisreduced)StemcelltherapyNumerousdrugsResearchdirectionsAppropriatThankyou!Thankyou!基底神經(jīng)節(jié)疾病基底神經(jīng)節(jié)疾病Outline1.IntroductionofbasalgangliaOverviewandfunction,structure,andconnections2.DisordersofbasalgangliaParkinson’sdiseaseHuntington’sdisease(symptomatology,pathology,pothogenesis,treatment…)Outline1.Introductionofbasal1.IntroductionofbasalgangliaOverviewandfunctionStructureConnections

1.IntroductionofbasalgangliThe

basalganglia

areagroupofnucleiinthebraininterconnectedwiththecerebralcortex,thalamusandbrainstem.

Functions:

motorcontrol,cognition,emotions,andlearning.Thebasalgangliaareagroup錐體系統(tǒng)錐體系統(tǒng)internalglobuspallidus(GPi)externalglobuspallidus(GPe)

internalglobuspallidus基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件ConnectionsConnectionsCircuitofBasalGangliaDirectpathwayIndirectpathwayNigrostriatalpathwayCircuitofBasalGangliaDirectGlutamateGABA

Dopamine

GlutamateDirect:

Motorcortex→Putamen→GPi→Thalamus→Motorcortex

Indirect:

Motorcortex→Putamen→GPe→Subthalamicnucleus→GPi→Thalamus→MotorcortexNigrostriatalpathway:

Parscompacta→StriatumGluGABAGABAGluGluGABAGABAGluGABAGluDirect:Motorcortex→Putam2.DisordersofBasalGangliaDiminishedmovement:Parkinson’sdiseaseExcessivemovement:HuntingtondiseaseNeuropsychiatriccognitiveandbehavioraldisturbances2.DisordersofBasalGangliaParkinson’sdisease,PD"AnEssayontheShakingPalsy"EnglishphysicianJamesParkinson(1817)IntroductionPDisthemostcommonneurodegenerativedisorderafterAlzheimer'sdisease.Parkinson’sdisease,PD"AnEssaTheprevalenceis0.3inthewholepopulationinindustrializedcountries,risingto1%inthoseover60yearsofageandto4%ofthepopulationover80.Meanageofonsetisaround60years,although5-10%ofcasesareconsideredofyoungonset(theageof20and50).Theincidenceisbetween8and18per100.000person-years.EpidemiologyTheprevalenceis0.3inthewMonographbyJamesParkinson1817SymptomatologyMovementdisorders:restingtremormusclerigiditybradykinesiaandposturalinstability

ParkinsonismCognitiveandneurobehavioralproblems(dementia)Sensoryandsleepdifficulties

chronicandprogressiveMonographbyJamesParkinsonSyTherelationshipofthebasalgangliatothemajorcomponentsofthemotorsystem.

TherelationshipofthebasalOriginsandterminationsof(a)thecorticospinaltractand(b)therubrospinaltract.Originsandterminationsof(a正常年青人,黑質(zhì)細(xì)胞數(shù)為42.5萬(wàn)

正常80歲老人,黑質(zhì)細(xì)胞數(shù)減少到20.0萬(wàn)

PD病人黑質(zhì)細(xì)胞數(shù)減少到少于10.0萬(wàn)

LewybodyPathology正常年青人,黑質(zhì)細(xì)胞數(shù)為42.5萬(wàn)

正常80歲老人,黑質(zhì)細(xì)胞Etiology

Etiology

PathogenesisCircuitdisorderofBasalGangliaGeneticDopamineoxidativestressToxinsOthersPathogenesisCircuitdisorderoCircuitdisorderofBasalGangliainhibitionofthedirectpathwayexcitationoftheindirectpathwayCircuitdisorderofBasalGang基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件多巴胺神經(jīng)元為何會(huì)發(fā)生黑質(zhì)部選擇性的退行性變呢?氧化應(yīng)激損傷1、外源性毒物的侵入2、神經(jīng)黑色素的存在3、DA的氧化應(yīng)激代謝4、清除自由基的能力不全多巴胺神經(jīng)元為何會(huì)發(fā)生黑質(zhì)部選擇性的退行性變呢?氧化應(yīng)激損傷圖31-5多巴胺在神經(jīng)元中的酶代謝及其代謝產(chǎn)物引自金國(guó)章,腦內(nèi)多巴胺的生物醫(yī)學(xué)1998年Fe2+Fe3+O2O2·ˉFe2+Fe3+O2O2·ˉH2O2多巴胺半醌多巴胺醌DAO2MAODOPACH2O2HVACOMTDopamineoxidativestress圖31-5多巴胺在神經(jīng)元中的酶代謝及其代謝產(chǎn)物Fe2+FeDopamineoxidativestressDopamineoxidativestressToxinsRotenone(aninsecticide)MPTP1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(1-甲基-4-苯基-1,2,3,6-四氫吡啶)Paraquat(aherbicide)6-Hydroxydopamine(6-OHDA)

HeavymetalsToxinsRotenone(aninsecticideRotenoneRotenoneMPTPMPTPParaquatParaquat6-Hydroxydopamine,or6-OHDA

6-Hydroxydopamine,or6-OHDATheneurotoxinsusedinanimalmodelsofPDinducemitochondrialdysfunction.Theneurotoxinsusedinanimal一種理想的動(dòng)物模型應(yīng)該符合下列5種標(biāo)準(zhǔn):

1.出生時(shí),應(yīng)有正常而完整的DAneurons,并在成年期開(kāi)始逐漸退化喪失且超過(guò)50%。

2.具有容易檢測(cè)的運(yùn)動(dòng)功能障礙。

3.Lewybodies的形成。

4.如模式是genetic,應(yīng)以單一點(diǎn)突變?yōu)榛A(chǔ)。

5.較短的時(shí)程,約數(shù)月。一種理想的動(dòng)物模型應(yīng)該符合下列5種標(biāo)準(zhǔn):

1.出生時(shí),應(yīng)有基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件Geneticmitochondrialdysfunction,oxidativedamage,abnormalproteinaccumulationandproteinphosphorylation

Geneticmitochondrialdysfuncti1.Synuclein(SNCA)/PARK1seenmainlyinpresynapticterminalsincludeα,βandγ-synucleinplayaroleinsynapticvesiclerecycling,storageandcompartmentalizationofneurotransmittersandassociateswithvesicularandmembranousstructures1.Synuclein(SNCA)/PARK1seenmSer129的磷酸化

-synuclein基因的倍增

Ser129的磷酸化

-synuclein基因的倍增Overviewofthea-synaggregationprocessintegratedwiththeoxidativestresspathwayandtheUPP.Overviewofthea-synaggregatParkinfunctionsasanE3ubiquitinproteinligasebytargetingmisfoldedproteinstotheubiquitnproteasomepathwayfordegradation,andthelossofitsE3ligaseactivityduetomutationsleadtoautosomalrecessiveearly-onsetPD.2.Parkin/PARK2ParkinfunctionsasanE3ubiqubiquitinproteasomesystem,UPS

ubiquitinproteasomesystem,UP3.PINK1(PTEN-inducedputativekinase1)/PARK6serine–threoninekinase(mitochondria)apivotalregulatorofmitochondrialquality3.PINK1(PTEN-inducedputative4.UCH-L1/PARK5utativekinase1(PINK1)Ubiquitincarboxyl-terminalhydrolaseL1neuron-specificproteinPGP9.5oneofthemostabundantproteinsinthebrain(2%)hydrolyticactivity,ligaseactivityandbindingmono-ub4.UCH-L1/PARK5utativekinase1PossibleroleofUCH-L1inPD.PossibleroleofUCH-L1inPD.基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件Mechanismsofneurotoxicant-inducedproteasomedysfunctionanddopaminergicdegeneration.Mechanismsofneurotoxicant-inTransgenicanimalmodelalpha-synucleinA30P+A53T,LRRK2(R1441G),parkin,R621Csynphilin-1…mouse,C.elegans,Drosophila,zebrafish

Transgenicanimalmodelalpha-Inflammation

Neuroinflammationismediatedpredominatelybymicroglia,theresidentimmuno-competentandphagocyticcellswithintheCNS.Microglia,representing5?20%ofbraincellsMicroglialcelldensityintheSNis4?5timeshigherthaninotherregionsActivatedcellsalsoproducepro-inflammatorymoleculesInflammation

Neuroinflammation基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件Schematicrepresentationoflipopolysaccharide(LPS)-inducedandglialactivation-mediateddopamine(DA)neurodegeneration.SchematicrepresentationoflKeymolecularmechanismsthatarewidelyacceptedtocontributetotheneurodegenerativeprocessindopaminergicneuronsinthesubstantianigrainParkinsondisease.KeymolecularmechanismsthatAtleasttwoofthethreemajorsymptomsarepresent.PossiblecausesforsymptomsResponsetolevodopaThemaintoolsusedtomakeadiagnosis:NeurologicalexaminationMotorphysiologytestsNeuro-imaging:PET(18-flurodopa),CT,MRI

Lewybodiesduringautopsy(goldstandard)

DiagnosisAtleasttwoofthethreemajo基底神經(jīng)節(jié)疾病優(yōu)質(zhì)課件Treatment

ThereisnoknowncureforParkinson'sdisease.Treatmentisaimedatcontrollingthesymptoms.Medicationscontrolsymptomsprimarilybycontrollingtheimbalancebetweenthetransmitters.TreatmentThereisnoknownTherapeuticstrategyDirectlyimprovethefunctionofdopamineneurotransmissionIndirectlyimprovethefunctionofdopamineSurgeryanddeepbrainstimulationTherapeuticstrategyDirectlyidopamine↑inthebrain

PrecursorRate-limitingstep,decreaseinPDL-dopadopamine↑inthebrainPrecursPeripheralinhibitorsThecentralandperipheralmetabolismoflevodopaanditsmodificationbydrugs.PeripheralinhibitorsThecentreasilypassthroughtheblood-brainbarrieristransformedintodopamineinthedopaminergicneuronsbyDDCisoftenmetabolisedtoDAelsewhere,causingawidevarietyofsideeffectsCOMTinhibitors,MAO-BinhibitorsL-dopaeasilypassthroughtheblood-Long-termeffectsofL-DOPA:

On/offoscillationsDosefailure(drugresistance)DopaminedysregulationsyndromeLong-termeffectsofL-DOPA:Ach:

movementAchincreasesinhibitionof

GABA.Adenosine:movementAdenosineincreasetheeffectsofAchontheGABAergicneurons;AdenosinecounterD2receptoractivity;AdenosinereducesGABArelease.Ach:movementEnkephalinDynorphinPeptidemodulationofstriatalinputtotheglobuspollidus.EnkephalinPeptidemodulationPallidotomyandSubthalamotomy

PallidotomyandSubthalamotomySurgeryisusedinpeoplewithadvancedPDforwhomdrugtherapyisnolongersufficient.Becausetheseprocedurescausepermanentdestructionofbraintissue,theyhavelargelybeenreplacedbydeepbrainstimulation(DBS)fortreatmentofParkinson'sdisease.SurgeryisusedinpeoplewithDBSisprimarilyusedtostimulateoneofthreebrainregions:thesubthalamicnucleus,theglobuspallidus,orthethalamus.DBSisprimarilyusedtostimuResearchdirections

Animalmodels

Genetherapy(virus)Neuroprotectivetreatments

(GDNF)Neuraltransplantation

Stemcellstransplantshaveraisedgreatrecentinterest.Whentransplantedintothebrainsofrodentsandmonkeystheysurviveandimprovebehavioralabnormalities.Neverthelesswhilefetalstemcellsaretheeasiesttomanipulatetheiruseiscontroversial.Suchcontroversymaybeovercomewiththeuseofinducedpluripotentstemcellsfromadults.

ResearchdirectionsAnimalmodAschemeofthegenerationofinducedpluripotentstem(iPS)cells.

(1)Isolateandculturedonorcells.(2)Transfectstemcell-associatedgenesintothecellsbyviralvectors.Redcellsindicatethecellsexpressingtheexogenousgenes.(3)HarvestandculturethecellsaccordingtoEScellculture,usingmitoticallyinactivatedfeedercells(lightgray).(4)AsmallsubsetofthetransfectedcellsbecomeiPScellsandgenerateES-likecolonies.

Aschemeofthegenerationof主要講解的內(nèi)容:1.

基底神經(jīng)節(jié)的腦內(nèi)組成的核團(tuán)、它們的分布、主要通路的組成及其參與調(diào)節(jié)每條通路中的神經(jīng)遞質(zhì)及其功能。2.

基底神經(jīng)節(jié)(黑質(zhì))損傷后的主要臨床表現(xiàn)及其病理表現(xiàn)的關(guān)系。3.PD腦內(nèi)黑質(zhì)多巴胺神經(jīng)元退化的機(jī)制研究。4.Parkinson’sDisease(PD)的治療方案及治療基礎(chǔ)。主要講解的內(nèi)容:思考題:1.Whatarethecomponentsofthebasalganglia?2.Howarethestructuresofthebasalgangliaconnected?3.Describethecorticostriatalprojections.4.Describetheconnectionsbetweensubthalamusandglobuspallidus.5.Describetheimportanceofthenigrastritalpathways.6.Whatistheroleofthebasalgangliainrelationtothemotorthalamus?7.Whataretheprincipalneurotransmittersandreceptorsassociatedwiththebasalganglia?8.Adisorderofthebasalgangliaisindicatedwhatsigns?9.Canadministrationofdopamine

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論